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[57) ABSTRACT 
Stimulated Raman spectroscopy is used to non-inva-
sively measure the concentration of an Raman active 
molecule, preferably D-glucose in the ocular aqueous 
humor ofliving being. The apparatus and method make 
use of two monochromatic laser beams, a pump laser 
beam and a probe laser beam. The output power of the 
pump laser beam is amplitude modulated, combined 
with the probe laser beam and directed into the ocular 
aqueous humor. The introduction of the laser beams 
into the ocular aqueous humor induces scattered Raman 
radiation, which causes a portion of the energy at the 
pump frequency to shift over to the probe frequency. 
The pump and probe laser beams are then detected as 
they exit the ocular aqueous humor. The probe laser 
beam is filtered, converted into an electrical signal and 
amplified. It is then compared to the modulation signal 
to generate an electrical signal representative of the 
concentration of D-glucose in the ocular aqueous hu-
mor. 
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NON-INVASIVE BLOOD GLUCOSE 
MEASUREMENT SYSTEM AND METHOD USING 
STIMULATED RAMAN SPECTROSCOPY 
BACKGROUND OF THE INVENTION 
A. Field of the Invention 
The present invention relates to a non-invasive 
method and apparatus for measuring the concentration 
of D-glucose in the ocular aqueous humor. More partic-
ularly, the present invention is a non-invasive technique 
for the in vivo measurement of the glucose concentra-
tion in the ocular aqueous humor employing the stimu-
lated Raman effect. 
5 
optical activity; i.e. based upon their ability to rotate the 
plane of polarization when illuminated with plane po-
larized light. In general, the specific rotation, [a], is 
defined as 
[a]= ~ (I) 
where a is the total optical rotation of the plane of 
10 polarization measured in degrees, L is the length of the 
sample in decimeters, and dis the density in g/cm3. The 
specific rotations of a-D-glucose and 13-D-glucose are 
112 and 19 degrees, respectively. In solution, one 
anomer is converted into the other as necessary to 
15 achieve an equilibrium solution which has a specific 
B. Background of the Invention rotation of 52.7 degrees. 
Diabetes Mellitus is a major health problem in the Since the specific rotation of D-glucose in solution is 
world today because of the physical complications known, from Equation (1) one can infer the concentra-
which arise from living many years with above-normal 0 tion of D-glucose in a given sample by measuring the blood glucose levels. Currently, over 11 million people 2 total optical rotation. The accuracy and linearity ob-
suffer from diabetes in the United States alone. The two served at very low D-gluccise concentrations led March 
most common forms of diabetes are Type I, juvenile- et al. to attempt non-invasive measurements in the eyes 
onset, and Type II, adult-onset. Type I diabetes de- of rabbits. See Rabinovitch, March and Adams, Non-
stroys the vast majority of the insulin-producing beta invasive Glucose Monitoring of the Aqueous Humor of the 
cells in the pancreas, forcing its sufferers to take multi- 25 Eye: Pan L Measurements of Very Small Optical Rota-
ple daily insulin injections. Type II diabetes is usually tions. 5 Diabetes Care 1254 (May-June 1982); March, 
less severe than Type I as some endogenous insulin Rabinovitch and Adams, Non-invasive Glucose Monitor-
production still occurs and, as a result, type II diabetes ing of the Aqueous Humor of the Eye: Part /I, Animal 
can often be cont~olle~ by .diet alone. . 30 Studies and the Sciera/ Lens, 5 Diabetes Care 259 (May--The ~o.dy re9uires m~ulm for many metaboh~ pro- June 1982). Unfortunately, March and his colleagues 
cesses; 1t 1s yart1~ularly important to the m~tabohsm ~f experienced great difficulty in measuring the concentra-
glu~ose. It is ~eheved.that many of the physical c.ompl~- tion of D-glucose in the ocular aqueous humor. Many 
cations associated with diabetes cou.ld J:>e av01ded 1f compounds in the ocular aqueous humor other than 
normal blood glu~ose ~e;els were mamtamed through- 35 D-glucose are optically active and contribute to the 
out eac~ day. A d1abet1c s blood gluco.se I7v.el can flue- rotation of the plane of polarization. In addition, the 
tuate widely around each meal: Mamtammg nor:mal cornea has birefringence, which causes a further rota-
bloo~ gluc?se levels and reducing these fluctuations tion of the plane of polarization of the incident light. See 
requ~res us1~g ~om~ form of feedback t? re~ulate the generally, Gough, The Composition of and Optical Ro-
mult1ple daily msulm shots of Type I diabetics or the t D"me · ifB · A H 5 D" b 
d. f t 11 d. b · 40 ary 1sr rswn o ovme queous umour, 1a etes 1et o ype 1a etlcs. . c 266 (M -J 1982) Currently, the blood glucose level can be determined a~e h ay une ·. 
by a chemical reaction performed on a blood sample. ot spontan7ous and stimulated Raman spectros-
Although the state of the art glucose measurement de- ".0 PY are potentially ~seful to me~ure the ~oncent:a-
vices are very accurate, the need for a blood sample for tlon of an Raman active molecule m a medrnm. W1~h 
each measurement limits their utility. The most dedi- 45 spontaneous. Ra.man sp~ctroscopy a mo~ochro~atlc 
cated diabetic patient may take only 4 or 5 measure- laser beam 1~ d~rected mto. a Ram~n-actlve med1~n:1· 
ments per day, and many diabetics perform even fewer. Some of the mc1dent ~e~m is transmitted, some ~fit is 
Because a diabetic's blood glucose level can fluctuate absorb~d, .and some ofi~ is s:atter~d. A small fraction of 
by a factor of two or more in a period of an hour, this ~he. rad1at1on scattered is shifted~ frequ7ncy from the 
method cannot provide the feedback necessary to main- 50 m:1d:nt beam. The am?unt .of this relative frequency 
tain a normal blood glucose level throughout the day. sh1~t is related to .the v1brat1~nal states of the Ram.an 
A non-invasive blood glucose measurement tech- active molecules m the ~ed1~m. The problem with 
nique would allow a large number of daily measure- ~pontaneou~ Rama.n sc~ttenng ~s that the Raman ~ower 
ments to be taken without the problems associated with is scattered m all ~Ir:ct10n~. This mak:s th7 detect10n of 
taking blood samples. VariOl.!S schemes have been at- 55 the scattered rad1at1on difficult for m vivo measure-
tempted to non-invasively measure blood glucose level. ments. 
Many promising techniques attempt to measure the Stimulated Raman spectroscopy (SRS) directs two 
glucose level in the ocular aqueous humor because it has monochromatic laser beams, a pump laser beam and a 
been shown that the ocular glucose level directly corre- probe laser beam, into a Raman active medium. If the 
!ates to the blood glucose level and because the ocular 60 power of the pump laser is modulated, then the sponta-
aqueous humor provides a much simpler spectroscopic neous Raman scattered power will also be modulated, 
environment than the blood. which will induce a signal on the probe laser beam. 
D-glucose occurs normally and in abundance in both Thus, rather than measuring the spontaneous Raman 
the blood and the ocular aqueous humor. There are two scattered power directly, a measurement of an intensity 
anomers ofD-glucose found in nature: a-D-glucose and 65 fluctuation of the probe laser beam can be made. 
13-D-glucose, which differ only in the orientation of the Stimulated Raman spectroscopy has been success-
groups attached to the C-1 carbon. Physically, these fully used to measure very low concentrations of cer-
two anomers of D-glucose can be distinguished by their tain selected organic liquids diluted by water and other 
5,243,983 
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the preferred embodiment the selected Raman active 
molecule is D-glucose and the separation between the 
probe wavelength and pump wavelength is chosen to be 
518 cm - I in accordance with the characteristic Raman 
5 shift spectrum for D-glucose. 
solvents. Owyoung and Jones performed a series of 
experiments with benzene using stimulated Raman scat-
tering techniques. See, Owyoung, Sensitivity Limitations 
for CW Stimulated Raman Spectroscopy, 22 Optics Com-
munications 323 (September 1977); Owyoung and Jones, 
Stimulated Raman Spectroscopy Using Low-Power CW 
Lasers, 1 Optics Letters 152 (November 1977). Their 
experimental set-up consisted of two lasers, a tunable 
pump laser and a fixed frequency probe laser. The pump 
laser Power was modulated while the probe laser power 
was held constant. The two laser beams were combined 
and focused through a benzene cell. In the cell the 
stimulated Raman effect caused a very small fraction of 
the Power at the pump wavelength to be shifted to the 
probe wavelength. Thus, at the output of the benzene 
cell the probe laser beam carried a small modulation 
signal whose amplitude was directly proportional to the 
concentration of the benzene in the cell. The probe 
wavelength was separated from the pump and con-
verted to an electrical signal by a photodiode. Both the 20 
probe signal and the input pump modulation signal were 
fed into a synchronous detector which greatly im-
proved the signal-to-noise ratio. The pump laser is then 
repeatedly tuned to new wavelengths to scan a range of 
wavelengths, thus, obtaining a Raman spectra for the 25 
Raman-active liquid or gas. This is the same type of 
spectrum obtainable by using a commercially available 
Raman spectrometer. 
The apparatus also includes a modulating means for 
modulating the output Power of the pump laser beam. 
A power source is provided for the probe laser for 
maintaining its power output substantially constant. 
10 The modulated pump laser beam is then combined with 
the probe laser beam by a means for directing the com-
bined laser beams into the ocular aqueous humor. 
The introduction of light into the ocular aqueous 
humor stimulates Raman radiation which shifts energy 
15 from the pump frequency to the probe frequency, 
thereby inducing fluctuations in the probe laser beam 
directly related to the concentration of the selected 
Raman active molecule in the ocular aqueous humor. 
After the probe laser beam exits the ocular aqueous 
humor, means are provided for detecting the probe 
laser beam and converting it into a Raman electrical 
signal. The Raman electrical signal is then compared to 
the modulation signal by a synchronous detector, a 
dynamic signal analyzer, or a computer based synchro-
nous detection system, to produce a voltage representa-
tive of the concentration of the Raman active molecule 
in the ocular aqueous humor. 
The method of the present invention non-invasively 
measures the in vivo concentration of an Raman active 
molecule in the ocular aqueous humor using stimulated 
Raman spectroscopy. Two monochromatic laser beams 
are provided, a probe laser beam and a pump laser 
beam. The probe laser beam and the pump laser beam 
wavelengths are separated from each other by a wave-
Until the present invention, no one has developed a 
technique which would allow for non-invasive in vivo 30 
measurement of the glucose concentration in the ocular 
aqueous humor. March attempted a non-invasive tech-
nique employing an energy wave transmitter, such as an 
infrared source located on one side of the cornea and an 
associated detector on the opposite side of the cornea. 
See U.S. Pat. No. 3,958,650. The wave source is aimed 
to cause the radiation to pass through the cornea and 
the aqueous humor to the detector. A transmitter is 
mounted adjacent to the detector and coupled thereto 
for transmitting a signal that is a function of the radia- 40 
tion level detected. This technique is seriously flawed. 
The radiation detected will be a function of the concen-
tration of all substituents in the humor, not just glucose. 
The later optical rotation technique of March, Rabino-
vitch and Adams suffers from a similar flaw. Further, 45 
no one, until now, has determined whether stimulated 
Raman spectroscopy may be successfully used to mea-
sure concentrations of glucose in the ocular aqueous 
humor. 
35 length within a characteristic Raman spectrum for the 
Raman active molecule being measured. In the pre-
ferred embodiment, the Raman active molecule is D-
glucose and the separation in frequency preferably 
chosen to be 518 cm - I. The output power of the probe 
laser beam should be maintained substantially constant, 
while the output power of the pump laser beam is mod-
ulated by a modulation signal. The probe laser beam and 
the modulated pump laser beam are combined and di-
rected into the ocular aqueous humor, thereby stimulat-
ing Raman scattered radiation. The probe laser beam is 
detected after it exits the ocular aqueous humor and 
converted into an electrical signal. The electrical signal 
is then compared with the modulation signal to produce 
a voltage representative concentration of the Raman 
SUMMARY OF THE INVENTION 
50 active molecule. 
It is, therefore, an object of the present invention to 
provide a system for measuring an Raman active mole-
cule in the ocular aqueous humor. 
It is another object of the present invention to pro-
vide a system for measuring very small D-glucose con-
centrations. 
It is Yet another object of the present invention to 
make non-invasive in vivo measurements of D-glucose 
concentration. 
It is a further object of the present invention to allow 
multiple daily measurements of D-glucose to be made 
non-invasively. 
A non-invasive blood glucose measurement tech-
nique would allow more frequent measurement of 
blood glucose concentrations without the problems 
associated with taking blood. samples. The present in- 55 
vention achieves this goal by providing an apparatus 
and a method for non-invasively measuring the in vivo 
concentration of an Raman active molecule in the ocu-
lar aqueous humor by using stimulated Raman spectros-
copy. The apparatus of the present invention includes a 60 
means for emitting a probe laser beam and a means for 
emitting a pump laser beam. Both means emit mono-
chromatic laser light and are separated in wavelength It is a still further object of the present invention to 
provide a non-invasive glucose measurement system 
65 which is inexpensive to manufacture, durable in con-
struction, and efficient in operation. 
by a wavelength chosen to be within a characteristic 
Raman shift spectrum for the Raman active molecule. 
By setting the separation in wavelength between the 
pump and probe lasers, one may select which one of a 
number of Raman active molecules will be measured. In 
These and other advantages will become apparent in 
the discussion below. 
5,243,983 
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BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a graph of the spontaneous Raman spectrum 
for D-glucose. 
FIG. 2 illustrates the stimulated Raman spectroscopy 5 
(SRS) wavelength selection for the preferred embodi-
ment. 
FIG. 3 is a block diagram of one embodiment of the 
present invention. 
FIG. 4 depicts the preferred amplitude modulation of 10 
the pump laser power versus time. 
FIG. 5 is a top view of an eye showing entering and 
exiting laser beams. 
6 
intensity fluctuation on the probe laser beam is made. 
This method is called stimulated Raman spectroscopy. 
As shown in FIG. 3, the present invention involves 
two lasers, a probe laser 20 and a pump laser 22. Both 
lasers 20 and 22 emit monochromatic laser beams. The 
relative wavelength difference between these two laser 
beams is adjusted to be the same as the wavelength shift 
of one of the largest spontaneous Raman peaks for D-
glucose, 518 cm-1. Other peaks unique to the D-
glucose spectrum may be chosen, for example, 400 
cm-I. 
The probe laser 20 chosen operates at a wavelength 
of approximately 0.83 micrometers with an output 
power of 20 mW. The probe laser power output should FIG. 6 illustrates the modulation of the detected 
probe laser power after extraction versus time. 
FIG. 7 illustrates the apparatus of the present inven-
tion for in vivo measurement. 
FIG. 8 is a block diagram an alternative embodiment 
of the present invention. 
15 remain substantially constant over time in order to mini-
mize errors in measurement. Thus, the sensitivity of the 
system is directly related to the ability to maintain the 
probe laser power output constant. The laser diode 
FIG. 9 is a block diagram of another alternate em- 20 
bodiment of the present invention using bulk optics. 
DETAILED DESCRIPTION 
When a monochromatic laser beam is incident on a 
Raman-active medium some of the incident beam is 25 
transmitted, some of it is absorbed, and some of it is 
scattered. A small fraction of the radiation scattered is 
shifted in frequency from the incident beam. The 
amount of this relative frequency shift is related to the 
vibrational states of the molecules in the medium. The 30 
D-glucose molecule has several possible Raman active 
vibrational states so that the Raman scattered power 
forms a spectrum which is characteristic of D-glucose 
alone. 
Turning now to the drawings in which like numerals 35 
denote corresponding parts the preferred embodiment 
of the present invention is shown. FIG. 1 illustrates the 
characteristic spectrum for D-glucose dissolved in 
water showing the relative intensity of spontaneous 
Raman power versus the frequency shift. Each of the 40 
peaks in the spectrum corresponds to a particular vibra-
tion of the D-glucose molecule, the largest peak occur-
ring at a frequency shift of 518 cm - I. The absolute 
intensities of the peaks are directly related to the con-
centration of the Raman-active molecule, in this case 45 
D-glucose. 
Use of a single monochromatic laser beam to generate 
spontaneous Raman scattering is difficult for in vivo 
measurements since the Raman power is scattered in all 
directions. This problem can be solved by having two 50 
monochromatic laser beams a pump laser and a probe 
laser) incident on the chosen sample. Thus, in the pre-
ferred embodiment, the probe laser is at the same fre-
quency as the Raman scattered power from a large peak 
in the D-glucose spectrum, as.illustrated in FIG. 2. The 55 
pump laser is at a frequency whose difference from the 
probe frequency is equal to the frequency shift of the 
large peak selected for the probe laser. In order to use 
stimulated Raman spectroscopy to measure the concen-
tration of D-glucose in the ocular aqueous humor, the 60 
frequency difference between the pump laser beam and 
the probe laser beam must be chosen to coincide with 
one of the peaks in the Raman spectrum for D-glucose. 
If the power output of the pump laser is modulated, 
then the spontaneous Raman scattered power will also 65 
be modulated which will induce a signal on the probe 
laser beam. Rather than measuring the spontaneous 
Raman scattered power directly, a measurement of an 
chosen, an SDL-1401-H2, is slightly tunable with tem-
perature. 
The pump laser 22 cho!ien emits light with a wave-
length of approximately 0.8 micrometers and an output 
power of 100 mW. The power output of the pump laser 
should ordinarily be greater than that of the probe laser 
by about 5 X depending upon the threshold conditions 
for the medium. The pump laser wavelength is also 
slightly tunable with temperature to allow fine adjust-
ment for optimal signal level. 
The actual wavelengths chosen for the pump and 
probe laser beams are not as important as the separation 
between them. That separation should correspond to a 
vibrational state of the Raman active molecule being 
measured. For example, should it be desirable to con-
centrate on the D-glucose peak at 400 cm- I, a different 
separation would be chosen for the wavelengths output 
by the probe and pump laws. The particular wave-
lengths of 0.8 and 0.83 were selected because of the 
availability of commercial diode lasers of such wave-
lengths. 
The pump laser beam is amplitude modulated by a 
biased square wave signal from signal generator 26. The 
output of signal generator 26 is used to modulate the 
current to the diode of the pump laser 22 thereby modu-
lating the amplitude of the output of the laser beam. The 
output of pump laser 22 is a biased square wave, with a 
maximum amplitude of approximately 100 mW and a 
minimum of approximately 0 mW. An example of am-
plitude modulated pump laser power over time is illus-
trated in FIG. 4. 
It is possible to use other types of modulation to mea-
sure the concentration of Raman active molecules using 
stimulated Raman spectroscopy. Amplitude modulation 
was chosen over other types of modulation, such as 
pulse width modulation, because amplitude modulation 
is easier to generate. Further, the type of modulation 
chosen affects the complexity of the detection scheme 
that must be used. The choice of modulation technique 
also affects the power incident upon the eye. Any tech-
nique which reduces this power reduces possible dam-
age to the eye and is to be preferred. 
The probe laser beam and the amplitude modulated 
pump laser beam are fed to a fiber optic coupler 28 via 
fiber optic pigtails 21. Only 50% of the power in the 
probe and pump laser beams is coupled into the fiber 
optic pigtails 21 due to their coupling efficiency. An-
other 50% of the power in the probe and pump laser 
beams is lost when the fiber optic pigtails 21 are joined 
together by optic coupler 28. Thus, the maximum 
7 
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power which could reach eye 40 is approximately 25 
mW when starting with a laser power output of JOO 
mW. 
46 compares output 45 to the output 27 of signal genera-
tor 26, and generates signal 49, which is representative 
of the concentration of D-glucose in the ocular aqueous 
humor. The synchronous detector output 49 may then 
be fed to any standard display element. 
Use of the lock-in amplifier involves using the pump 
laser modulation signal as an external reference signal 
and feeding the SRS signal into the signal input of the 
amplifier. The bandpass filter for the external reference 
Fiber optic coupler 28 combines the probe and modu-
lated pump laser beams and directs them into an op- 5 
tional spatial filter 30. The spatial filter 30 converts the 
cross-section intensity to a Guassian Distribution which 
allows the beam to be focused more precisely and in-
sures the complete combination of the two wavelengths 
before the laser beams are directed into the eye 40. 
The combined laser beams travel through fiber optic 
c;ables associated with means for delivering the laser 
beams to the eye, preferably in the form of a handset 
(not shown). The handset is held up against eye 40 and 
directs the probe and modulated pump laser beams into 15 
the ocular aqueous humor. The trajectory of incident 
laser beams 60 can be seen in FIG. 5. The laser beams 60 
are passed through the cornea 36 and the aqueous 
humor 38 in such a manner as to bypass the lens 32 and 
the iris 34. Pump and probe beams 60 excite stimulated 20 
Raman radiation while inside the ocular aqueous humor 
38. The scattered Raman radiation causes a small 
amount of the energy at the pump frequency to be 
shifted to the probe frequency, thereby inducing fluctu-
ations in the previously constant power level of the 25 
probe laser beam, as illustrated in FIG. 6. These fluctua-
tions in the probe laser beam power are directly related 
10 may need to be tuned to the pump modulation fre-
quency depending on the model of the lock-in amp. A 
phase offset between the reference and the SRS signal 
should be zeroed as indicated in the installation manual. 
to the concentration ofD-glucose in the ocular aqueous 
humor 38. The now modulated probe laser beam and 
the pump laser beam exit the eye and are coupled into 30 
an optical fiber in the handset-cable assembly. 
The coupled detected laser beams are passed through 
a set of cascaded narrow band interference filters 42. 
These optional filters are centered at the probe wave-
length plus or minus about 5 nm, thereby filtering the 35 
pump laser beam away from the probe laser beam. 
Thus, ifthe probe wavelength is set at 0.83 microns, the 
band width (BW) for the filters would be BW = 825 
nm< A< 835 nm. The filters are cascaded because the 
desired reduction in the pump laser power cannot be 40 
achieved with a single filter. Further reduction in the 
power of the pump wavelength may be accomplished 
with a prism or grating. Thereafter, the modulated 
probe laser beam is applied to a photo-voltaic diode in 
photodetector/amplifier 44, which outputs an electrical 45 
signal. The photo-voltaic diode provides a current out-
put in relation to the amount of light input. The 
photodetector/amplifier 44 includes a low-noise ampli-
fier which amplifies the low current level output of the 
photo-voltaic diode to achieve a voltage level compati- 50 
ble with the circuitry of the synchronous detector 46. A 
transresistance gain of greater than 1Q8 is achieved by 
the low noise amplifier, which also filters off the large 
DC bias. 
Then the appropriate gain setting for the SRS input 
signal should be set. The time constant or integration 
time setting may vary depending upon the noise present 
on the signal. The DC output signal may be read from 
the meter in the unit or directed to an external display. 
An alternative, and more costly method of generating 
a representative electrical signal from the photodetec-
tor/amplifier 44 output is to feed output 45 to a dynamic 
signal analyzer 48, such as an HP 3561 made by Hewl-
ett-Packard. Analyzer 48 measures the power contained 
in the detected probe laser beam at the modulation 
frequency. This power is likewise related to the D-
glucose concentration. Thus, it is possible to use at least 
two independent methods to calculate the D-glucose 
concentration. 
The procedure for the dynamic signal analyzer in-
volves connecting the SRS signal to the input jack of 
the analyzer. The soft key programming is generally 
discussed in the user's manual for the analyzer. The 
frequency span should be set to a center frequency 
equal the pump modulation frequency and a span of 
about 100 Hz which may vary depending upon signal 
noise. Preferably, the unit should also be programmed 
to RMS average 50 samples. There is a setting for peak 
tracking which will display a numerical value for the 
frequency peak in the local portion of the signal spec-
trum which is currently displayed. The vertical scale 
units should be set to "linear" and thus the value for the 
SRS signal corresponding to the glucose concentration 
will be the value of the peak frequency component. The 
numerical value is displayed on the screen of the analy-
zer. 
Before using the apparatus of the present invention 
background measurements should be made to establish 
a signal reference point and to be certain that there are 
no spurious signals in the passband of the low noise 
amplifier which forms part of the photodetector/am-
plifier 44. A noise spectrum measured by the synchro-
nous detector 46 with only the probe laser turned on 
should be made. Another important background mea-
surement is pump laser power "leakthrough". Although 
the two narrow band. interference filters filter the pump 
wavelength, some small amount of pump power still 
reaches the detector 46. Since this signal is present 
whenever the pump laser is on, it will offset other mea-
surements. In addition to the presence of pump leak-
through, stimulated Raman scattering takes place in the 
fiber optic cables 21 which carry the input power to the 
eye 40 and this SRS signal offsets the SRS signal from 
D-glucose in the ocular aqueous humor. These offset 
signals do not directly limit the sensitivity of the D-
The operating band of the low noise amplifier is de- 55 
termined by the noise spectrum of the probe laser. The 
noise spectrum of the probe laser is relatively constant 
between 1-10 kHZ, and increases below this frequency 
range. Restricting the passband of the low noise ampli-
fier to this frequency range helps eliminate undesired 60 
noise from the probe laser. Those skilled in the art will 
understand that the passband chosen depends upon the 
noise spectrum particular to the laser used as the probe 
laser. Different lasers may be expected to require differ-
ent low noise amplifiers. 65 glucose measurement since the SRS signal from the 
D-glucose adds to the offset signals and thus the offset 
signals can be subtracted out in the calculation of the 
D-glucose concentration. But the relative amplitude of 
The output 45 of the photodetector/amplifier 44 is 
fed to synchronous detector 46, such as a Princeton 
HR-8 PAR lock-in amplifier. The synchronous detector 
9 
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these offset signals does limit the detector gain which optic cable to transport the SRS optical signal to the 
ultimately limits the system sensitivity. photo detector. The pump laser beam is filtered from 
Occurring naturally in the ocular aqueous humor, the probe laser beam using a series of narrow band 
water is also a Raman-active molecule. There is no peak filters incorporated into the photodetector /amplifier 
present in the Raman spectrum for water at the fre- 5 144. The modulated pump probe laser beam is then 
quency shift of 518 cm-1; even so, some broad features transduced from an optical signal into an electrical sig-
of the water spectrum will produce an SRS signal at a nal using a photo-voltaic diode. The electrical output 
shift of 518 cm -1. This SRS signal from water contrib- from this diode is thereafter amplified using an ex-
utes to the offset signal and should be subtracted out in tremely large gain, low noise amplifier incorporated in 
the calculation of D-glucose concentration. 10 photodetector/amplifier 144 to achieve the signal levels 
A schematic of the present invention for in vitro compatible with a detection scheme. The amplifier's 
measurement can be seen in FIG. 7. The entire appara- gain is on the order of 108. The amplifier's passband 
tus is mounted on a wheeled cart 68. The pump laser corresponds to a frequency range in which the probe 
(SDL-2412-H2) and its power supply 72 are mounted laser's noise spectrum is substantially constant. The 
vertically on one side of the cart, while the probe laser 15 output of the photodetector/amplifier 144 is then fed 
(SDL-2412-H2) and its power supply 70 are mounted into a computer-based synchronous detector 156. 
vertically on the opposite side of the cart. The preferred Five percent of the probe laser power is applied to 
power supply for the probe laser is an LDX 3620 by the photodetector/amplifier 152, which is substantially 
ILX lightwave, Montana, because of its low noise cur- similar to photodetector and amplifier 144 and which 
rent to the laser diode and constant power mode having 20 generates an electrical signal representative of the probe 
an automatic compensation feature. Outputs from each laser beam power. This output may then be fed to an 
of the pump and probe lasers are fed by optical fiber optional time delay 154 to compensate for the delay of 
pigtails 73 to a fiber optic coupler 75. The pigtails are the laser beam through the spatial filter, fiber optic 
multi-mode fiber optic cables to match those supplied coupler and photodetector amplifier path. However, 
with the lasers. The combined probe and pump laser 25 since this time delay is small and is physically hard to 
beams are then fed by fiber optic cables 76 from the realize, time delay 154 may also be eliminated without 
fiber optic coupler 75 up to the spatial filter 77 and from substantially effecting the accuracy of the D-glucose 
there into an eye, or alternatively, into a glucose test measurement. 
cell 78, shown in place on a table behind the cart. The The computer-based synchronous detector 156 com-
spatial filter 77 is preferably a Model 900 from Newport 30 pares the photodetector/amplifier output 144 with the 
Optics. Glucose test cells 78 are used for in vitro mea- output of the AM modulator 126 and photodetector-
surement. The test cell 78 is machined plastic with spe- /amplifier 152 output, allowing the computer-based 
cial windows of a high quality, low impurity glass with synchronous detector 156 to compensate for amplitude 
a special coating to reduce reflections of optical wave- variations in the probe laser beam caused by internal 
lengths selected for the lasers. Preferred coatings in- 35 noise and thermal drift of the probe laser. A data acqui-
clude a magnesium fluoride or a coating broadband near sition/interface board to the computer connects the 
infrared coating like Newport #Ar.16. signals from photodetector/amplifiers 144, 152 to the 
A set of interference filters 79, previously described, computer. The data acquisition/interface board prefera-
receive the pump and probe laser beams as they exit the bly consists of 3 primary AID channels. Two of these 
glucose cell 78. Fiber optic cable 81 passes the detected 40 channels are 16-bit resolution and the third channel is 
laser beams from filters 79 to detector unit 74, which only 8-bit resolution. The 16-bit channels are used to 
houses both the photo-voltaic diode and the low noise convert the SRS signal and the PROBE Noise signal, 
amplifier. The output from the detector unit 74 is then while the 8-bit channel converts the modulation signal. 
fed to the synchronous detection unit. A switchable The specifications should meet or exceed the following: 
laser temperature readout 82 may be provided to moni- 45 16-bit Converters-Analog Devices (1376A) 
tor the output of lasers 70, 72. 16-bit Track-Hold-Analog Devices (389KD) 
A block diagram of an alternative embodiment of the Amplifiers 
present invention is shown in FIG. 8. The alternative 8-bit Converter-Analog Devices (574A) 
apparatus incorporates both a probe laser 120 and a 8-bit Track-Hold-Analog Devices (HTC-0300) 
pump laser 122. These lasers are both monochromatic 50 A sampling rate of 10 KHz is used so the Nyquist fre-
and both operate at the same wavelengths discussed quency is 5 KHz. Appropriate anti-aliasing filters 
hereinabove with respect to the preferred embodiment should be used prior to conversion which limit the 
of FIG. 3. The pump laser 122 is modulated using an bandwidth of the input signals to ~5KHz. Also there 
AM modulation source 126, such as Hp 3314A. are four secondary AID inputs to monitor various 
The output of probe laser: 120 is connected to an 55 background activities like laser temperature. Once the 
optical coupler 150 which is reversed to split the probe analog signals are converted to digital values they are 
laser output into two beams, one containing 5% and the converted to floating point numbers and stored in mem-
other containing 95% of the probe laser power. ory arrays by low level programming. Currently the 
Another fiber optic coupler 128 combines ninety-five data is processed by algorithms to yield a stable SRS 
percent of the probe laser power with the modulated 60 value for a given glucose concentration. These algo-
pump laser beam and outputs the combined beams to rithms include the following: 
spatial filter 130. Using a handset (not shown) the com- 1) The use of infinite impulse response (IIR) filters, 
bined beams are then directed into the eye 140. Inside such as a Butterworth filter, to further narrow the 
the ocular aqueous humor of the eye 140 stimulated bandwidth of the signal. 
Raman radiation causes a portion of the power at the 65 2) The subtraction of amplitude noise originating on 
pump frequency to be shifted to the probe frequency, the PROBE Laser. 
thereby modulating the probe laser beam. As the pump 3) A conventional cross-correlation algorithm to 
probe beams exit the eye they are coupled into a fiber yield a final result. 
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pump laser's optical power is modulated by an optical 
chopper 226 which yields an equivalent optical power 
modulation to the optical fiber based system. 
3) A key addition to this system is an optical isolator 
An alternate approach to the optical fiber band sys-
tem described above would be to use entirely bulk op-
tics in the system, thus eliminating the optical fibers 
completely. This bulk optics implementation, although 
more costly, will yield a higher system sensitivity than 
the optical fiber based system. This arises from the elim-
ination of one of the sources of "leak through" signals 
and the conversion to single-mode laser diodes. Current 
technology limits the use of these high power single-
mode laser diodes to a bulk optic system. These single-
mode laser diodes concentrate their optical power into 
a much narrower spectral line which will greatly im-
prove the SRS signal to noise ratio. 
5 224, 225 which is used with each laser diode to minimize 
reflections of the optical power back into the laser cav-
ity. This is very important since the reflected power can 
cause the laser diode to change its wavelength during 
operation. This phenomenon has been observed in the 
10 optical fiber based system. 
4) The spatial filter 230 is now required to insure that 
the optical power from each laser is collinearly focused 
through the glucose solution 240. The glucose solution 
may be in an optical test cell or in the ocular aqueous As illustrated in FIG. 9, the output of each laser 
220,222 of the bulk optic system is delivered to beam 
collimating optics 221, 223, which preferably consist of 
15 humor. 
The addition of the optical spectrum analyzer 264 is 
optional. Its purpose is to monitor a portion of the opti-
cal power to insure the proper optical wavelengths are 
present. Also the wavelengths for the single-mode laser 
diode have been changed slightly due to the availability 
from the manufacturer. The difference between these 
two wavelengths still corresponds to a frequency differ-
ence of 518 cm-1 as previously discussed. 
It will be obvious to those skilled in the art that many 
a pair of cylindric lenses for each laser, to focus the laser 
beam along their orthogonal axes to make a collimated 
beam from the asymmetrical cone shaped output of the 
lasers. Optical isolators 224, 225 are provided to prevent 20 
reflection of the beams back into the lasers. The isola-
tors can be broad band isolators covering the band 
width of 750 to 950 nm, such as the Newport IS0-7885 
optical isolator. The output of pump laser 222 passing 
through optical isolator 224 is delivered to an optical 
chopper 226 or electric optic modulator which prefera-
bly operates at 1 kHz, though may be operated at differ-
ent frequencies depending on the modulation desired 
for the pump laser output. Beam samplers 227, 260 are 
provided to reflect a small sample portion of the beam 
25 variations may be made in the embodiment chosen for 
the purpose of illustrating the best mode of making and 
operating the present invention, without departing from 
the scope thereof as defined by the appended claims. 
We claim: 
30 1. A method ofnon-invasively measuring the concen-
tration of a Raman active molecule in ocular aqueous 
humor using stimulated Raman spectroscopy, compris-
ing the steps of: 
generating a modulation signal; 
or beams, the amount of the sample depending upon the 
angle of placement of the beam sampler in the path of 
the beam. Beam sampler 227 is used to provide a small 
sample of the probe laser output to the photodetector 
and amplifier 252, the output of which 254 provides a 
probe laser noise signal to the computer based synchro-
nous detection system 256. Beam sampler 260 provides 
35 emitting a probe laser beam having a first wave-
a small sample of the beams provided to the spatial filter 
230. The output of the photodetector and amplifier 262 
coupled with the beam sampler 260 provides a synchro- 40 
nous detection reference signal 266 to the computer 
based synchronous system 256. An optical spectrum 
analyzer 264 is used to monitor the beams provided to 
the spatial filter 230 in the laboratory setting because the 
single mode lasers have a tendency to "mode hop" and 45 
change the wavelength of their output. 
The rest of the path in FIG. 9 beginning with the 
spatial filter 230, the glucose sample 40 through to the 
computer based synchronous detection system 256 is 
the same as the embodiments discussed above with the 50 
exception of the addition of the prism or grading 241. If 
a prism is used, a standard dispersing prism is preferred. 
From the bulk optic system block diagram of FIG. 9 
one can see that this system is functionally equivalent to 
the optical fiber based systel!l· The major differences 55 
between the two implementations are as follows: 
1) Now of the polarization of the optical fields must 
length; 
emitting a pump laser beam having a second wave-
length differing from said first wavelength by a 
third wavelength selected to be within a character-
istic Raman shift spectrum for the Raman active 
molecule; 
modulating said pump laser beam using said modula-
tion signal; 
directing said probe laser beam and said modulated 
pump laser beam into the ocular aqueous humor 
thereby stimulating Raman scattered radiation, said 
Raman scattered radiation inducing fluctuations in 
said probe laser beam, said fluctuations being re-
lated to the concentration of the Raman active 
molecule in the ocular aqueous humor, said probe 
laser beam exiting the ocular aqueous humor; 
detecting said probe laser beam after it exits the ocu-
lar aqueous humor; 
converting said detected probe laser beam into a 
Raman electrical signal; and 
producing a signal representative of the concentra-
tion of the Raman active molecule in the ocular 
aqueous humor from said Raman electrical signal 
and said modulation signal. 
be carefully controlled. It is vitally important that 
both the pump laser wavelength and the probe 
laser wavelength have nearly the same polarization 
of their optical fields. Here linear polarization is 
maintained throughout the system. 
60 2. The method of claim 1 wherein said Raman active 
2) Due to technological limitations, the pump single-
mode laser diode's optical power cannot be modulated 
by the modulation of its current. This is due to the fact 65 
that the wavelength of the laser diode's output power 
does depend upon its current. Thus, both laser diodes 
are operated with a constant current source. Now the 
molecule is D-glucose. 
3. The method of claim 2 wherein said first wave-
length is about 0.83 µm. 
4. The method of claim 3 wherein said second wave-
length is about 0.8 µm. 
5. The method of claim 1 wherein the step of modu-
lating said pump laser beam comprises amplitude modu-
lating said pump laser beam. 
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6. The method of claim S wherein said step of emit-
ting the probe laser beam includes maintaining the 
power output of the probe laser beam substantially 
constant. 
7. The method of claim 1 further comprising the step 5 
of spatially filtering said probe laser beam and said mod-
ulated pump laser beam before said directing step. 
8. The method of claim 1 further comprising the step 
of amplifying said Raman electrical signal. 
9. The method of claim 1 wherein the step of produc- 10 
ing a signal representative of the Raman active mole-
cule includes digital signal analyzing the Raman electri-
cal signal to produce an electrical signal representative 
of the concentration of the Raman active molecule. 
10. The method of claim 1 wherein the step of pro- 15 
ducing a signal representative of the Raman active mol-
ecule includes use of a synchronous detector to produce 
the signal representative of the Raman active molecule. 
11. The method of claim 1 wherein the power output 
of the pump laser is maintained at a higher level than the 20 
power output of the probe laser beam. 
14 
19. The apparatus of claim 12 further compnsmg 
means for digital signal analysis of said detected probe 
laser beam to produce an electrical signal representative 
of the Raman active molecule. 
20. The apparatus of claim 12 wherein said means for 
detecting and said means for converting comprise a 
photodetector. 
21. The apparatus of claim 12 wherein said means for 
producing said signal representative of the Raman ac-
tive molecule comprises a synchronous detector. 
22. The apparatus of claim 21 wherein said modulat-
ing means comprises an amplitude modulator. 
23. The apparatus of claim 21 wherein said means for 
detecting comprises a dynamic signal analyzer. 
24. The apparatus of claim 12 wherein said means for 
said signal representative of said Raman active molecule 
comprises a dynamic signal analyzer. 
25. The apparatus of claim 24 wherein said wave-
length is about 0.83 µm. 
26. The apparatus of claim 12 wherein said means for 
producing said signal representative of said Raman 
active molecule comprises a computer based synchro-
nous detection system. 
12. An apparatus for non-invasively measuring the 
concentration of an Raman active molecule in ocular 
aqueous humor using stimulated Raman spectroscopy, 
comprising: 
27. The apparatus of claim 26 wherein said second 
25 wavelength is about 0. 8 µm. 
means for generating a modulation signal; 
means for emitting a probe laser beam having a first 
wavelength; 
means for emitting a pump laser beam having a sec-
ond wavelength differing from said first wave- 30 
length by a third wavelength selected to be within 
a characteristic Raman shift spectrum for the 
Raman active molecule; 
28. The apparatus of claim 12 wherein the means for 
emitting a probe laser beam includes a power supply for 
maintaining the output of the probe laser substantially 
constant. 
29. The apparatus of claim 12 wherein the signal 
representative of said Raman active molecule is repre-
sentative of the concentration of said Raman active 
molecule. 
modulating means for modulating said pump laser 
beam using said modulation signal; 
30. The apparatus of claim 29 wherein said means for 
35 emitting a probe laser beam emits said probe laser beam 
having a substantially constant amplitude. means for directing said probe laser beam and said 
modulated pump laser beam into the ocular aque-
ous humor thereby stimulating Raman scattered 
radiation, said Raman scattered radiation inducing 
fluctuations in said probe laser beam said fluctua- 40 
tion being related to the concentration of the 
Raman active molecule in the ocular aqueous hu-
mor; said probe laser beam exiting the ocular aque-
ous humor; 
means for detecting the probe laser beam after it exits 45 
the ocular aqueous humor; 
means for converting said detected probe laser beam 
into a Raman electrical signal; and 
means for producing a signal representative of the 
concentration of the Raman active molecule in the 50 
ocular aqueous humor from said modulation signal 
and said Raman electrical signal. 
13. The apparatus of claim 12 wherein said first wave-
length is about 0.83 µm. 
14. The apparatus of claim 13 wherein said second is 55 
about 0.8 µm. · 
15. The apparatus of claim 12 wherein said means for 
emitting said probe laser beam comprises a first mono-
chromatic laser. 
16. The apparatus of claim 12 wherein said means for 60 
emitting said pump laser beam comprises a second 
monochromatic laser. 
17. The apparatus of claim 12 wherein said means for 
directing includes a fiber optic coupler and fiber optic 
cable. 
18. The apparatus of claim 12 further comprising 
means for amplifying said Raman electrical signal. 
65 
31. An apparatus for non-invasively measuring the 
concentration of a Raman active molecule in the ocular 
aqueous humour, comprising: 
a probe laser emitting a probe laser beam, having a 
first wavelength; 
a pump laser emitting a pump laser beam, having a 
second wavelength which second wavelength dif-
fers from said first wavelength by an amount se-
lected to be within a characteristic Raman shift 
spectrum for the Raman active molecule; 
a modulator means for producing a modulation signal 
and for modulating said pump laser beam; 
a fiber optic coupler receiving said probe laser beam 
and said modulated pump laser beam and directing 
said laser beams into the ocular aqueous humor 
thereby stimulating Raman scattered radiation, said 
Raman radiation inducing fluctuations in said 
probe laser beam, said fluctuations being related to 
the concentration of the Raman active molecule in 
the ocular aqueous humor, said probe laser beam 
exiting the ocular aqueous humor; 
a photodetector receiving said probe laser beam and 
producing an electrical signal; and 
an amplifier means for developing a de voltage repre-
sentative of the concentration of the Raman active 
molecule in the ocular aqueous humor from said 
electrical signal and 
said modulation signal. 
32. The apparatus of claim 31 wherein said photode-
tector comprise a synchronous detector. 
* * * * * 
